CX Institutional’s iShares MSCI Australia ETF EWA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-428
Closed -$10.4K 548
2023
Q4
$10.4K Buy
+428
New +$9.48K ﹤0.01% 521
2023
Q1
Sell
-342,550
Closed -$7.61M 505
2022
Q4
$7.61M Buy
342,550
+77,737
+29% +$1.69M 0.46% 53
2022
Q3
$5.2M Buy
264,813
+120,840
+84% +$2.63M 0.36% 71
2022
Q2
$3.06M Sell
143,973
-36,485
-20% -$881K 0.23% 109
2022
Q1
$4.77M Sell
180,458
-7,811
-4% -$191K 0.38% 67
2021
Q4
$4.67M Buy
188,269
+3,567
+2% +$90.9K 0.37% 84
2021
Q3
$4.58M Sell
184,702
-2,288
-1% -$59.1K 0.37% 75
2021
Q2
$4.86M Buy
186,990
+186,073
+20,291% +$4.9M 0.4% 75
2021
Q1
$23K Sell
917
-135,214
-99% -$3.36M ﹤0.01% 647
2020
Q4
$3.26M Buy
136,131
+135,986
+93,783% +$3.01M 0.31% 82
2020
Q3
$3K Sell
145
-331
-70% -$6.7K ﹤0.01% 780
2020
Q2
$9K Sell
476
-177,370
-100% -$3.13M ﹤0.01% 574
2020
Q1
$2.76M Buy
177,846
+54,496
+44% +$1.12M 0.45% 52
2019
Q4
$2.79M Sell
123,350
-2,091
-2% -$47.1K 0.49% 53
2019
Q3
$2.79M Buy
+125,441
New +$2.77M 0.45% 59

Other funds holding EWA

CX Institutional's EWA Position: Q1 2024 in Review

CX Institutional sold out of iShares MSCI Australia ETF (EWA) in Q1 2024, closing a stake of 428 shares — an estimated $10.4K sold.

CX Institutional first reported a position in EWA in Q3 2019 and held it in 15 quarters. The position peaked at $7.61M in Q4 2022. 181 funds tracked by Wall St. Rank hold EWA as of Q1 2024.

  • CX Institutional reported no remaining iShares MSCI Australia ETF position as of Q1 2024 after selling out during the quarter.
  • CX Institutional sold 428 iShares MSCI Australia ETF shares in Q1 2024, an estimated $10.4K.
  • CX Institutional first reported a position in iShares MSCI Australia ETF in Q3 2019 and held it in 15 quarters.
  • CX Institutional's iShares MSCI Australia ETF position peaked at $7.61M in Q4 2022.
  • 181 funds tracked by Wall St. Rank held iShares MSCI Australia ETF as of Q1 2024.

Based on CX Institutional's 13F filing for Q1 2024, filed 15 Apr 2024.